Omicron variant reignites calls for Canada to support waiving of COVID-19 vaccine IP

In light of the emergence of the new Omicron variant of concern, calls are mounting once again for Canada to support a global initiative to temporarily waive intellectual property restrictions on COVID-19 vaccines.